All stock lists
Rezolve AI Limited Warrants (NASDAQ:RZLVW)
GB · Delayed Price · Currency is USD
Technology · Software - Application
0.20+0.06 (+43.57%)
Market cap
$169M
Insider Score
Health Score
Listed since
Feb 15, 2000
Website
Insider Score
––Not scored
RZLVW Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Distressed
From RZLVW’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $177.7M
- Net income
- -$320.8M
- Net margin
- -180.6%
Leverage15 / 20
Little or no net debt.
- Total debt
- $184.4M
- Cash
- $100.5M
- Debt / equity
- 0.46
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $200.3M
- Current liabilities
- $405.6M
- Current ratio
- 0.49
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$153.6M
- Free cash flow
- -$189.6M
- FCF margin
- -106.7%
Dilution & runway2 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 402.9M
- Share growth (1y)
- -56.6%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
RZLVW Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 130.79 M | 40.48 M | 6.32 M | 67.19 K | 26.70 K | 98.29 K |
| Revenue Growth (YoY) | 489742.70 % | 41088.71 % | 13408.15 % | 101.21 % | -99.06 % | — |
| Cost of Revenue | 87.28 M | 15.65 M | 276.05 K | 8.94 K | 8.09 K | 18.68 K |
| Gross Profit | 43.51 M | 24.84 M | 6.04 M | 58.26 K | 18.61 K | 79.61 K |
| SG&A Expense | 151.65 M | 65.55 M | 36.88 M | 64.11 M | 485.11 K | 637.84 K |
| R&D Expense | 19.94 M | 11.20 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 171.59 M | 79.27 M | 38.47 M | 64.25 M | 4.85 M | 637.84 K |
| Operating Income | -128.08 M | -54.43 M | -32.42 M | -64.19 M | -485.00 K | -638.00 K |
| Pretax Income | -143.97 M | -61.78 M | -57.36 M | -79.89 M | -334.00 K | -251.00 K |
| Tax Provision | -4.49 M | -18.22 M | 494.25 K | 7.47 K | 47.08 K | 89.72 K |
| Net Income | -139.48 M | -43.56 M | -57.85 M | -79.90 M | -381.00 K | -340.00 K |
| EPS (Basic) | -0.35 | -0.13 | -0.24 | -0.38 | -0.01 | -0.04 |
| EPS (Diluted) | -0.35 | -0.13 | -0.24 | -0.38 | -0.01 | -0.04 |
| Shares Outstanding | 402.92 M | 333.31 M | 231.41 M | 208.26 M | 927.89 M | 8.07 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.